Impact of Aggressive Empiric Antibiotic Therapy and Duration of Therapy on the Emergence of Antimicrobial Resistance During the Treatment of Hospitalized Subjects With Pneumonia Requiring Mechanical Ventilation

Trial Profile

Impact of Aggressive Empiric Antibiotic Therapy and Duration of Therapy on the Emergence of Antimicrobial Resistance During the Treatment of Hospitalized Subjects With Pneumonia Requiring Mechanical Ventilation

Discontinued
Phase of Trial: Phase II

Latest Information Update: 24 Apr 2017

At a glance

  • Drugs Meropenem (Primary) ; Amikacin; Gentamicin; Tobramycin; Tobramycin
  • Indications Acinetobacter infections; Pneumonia; Pseudomonal infections
  • Focus Therapeutic Use
  • Acronyms VABP
  • Most Recent Events

    • 17 Sep 2015 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 23 Nov 2013 New source identified and integrated (European Clinical Trials Database; EudraCT2012-003483-46).
    • 01 Jan 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top